MBTPS1 and hepatocellular carcinoma: On the other hand, serum ceramides and sphingolipids such as S1P and SA1P are increased in patients with HCC but not in cirrhotic controls [45], and the blockade of sphingolipids in Huh7 and HepG2 cell lines leads to increased susceptibility to sorafenib [46].